Eledon Pharmaceuticals, Inc.
ELDN· Nasdaq
Released Nov 12, 2019, after the close
10-Q filed Nov 13, 2019, 44 days after period end · 0001564590-19-043039
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Revenue | — | — | — | $0.00 |
| Net Income | -$2.89M | -$3.50M | -$2.97M | -$2.04M |
| EPS Diluted |
Eledon Pharmaceuticals, Inc. · CIK 1404281 · Engraved from SEC EDGAR
| -$4.01 |
| -$0.37 |
| -$0.43 |
| -$4.35 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.